IPGP vs REGN
IPG Photonics Corporation (IPGP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
IPG Photonics Corporation (IPGP) is a semiconductor equipment & materials company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported IPGP revenue for 2024-12-31 was $977.1M. Net income was -$181.5M. Revenue was down 24.1% from 2023-12-31 to 2024-12-31. IPGP currently screens at market cap $4.56B and trailing P/E 157.9.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
IPGP currently screens at market cap $4.56B and trailing P/E 157.9. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the IPGP and REGN stock pages for the full models.
Not investment advice.